XRCC5 and non-small cell lung carcinoma: We examined if the upregulation of KU80 or p-DNA-PKcs in the NHEJ pathway activates NF-κB in DDP-resistant NSCLC, aiming to clarify DNA-PKcs’s role in NF-κB signaling and its impact on DDP resistance.